COGT logo

Cogent Biosciences (COGT)

Profile

Full Name

Cogent Biosciences, Inc.

Ticker Symbol

COGT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 29, 2018

Indexes

Not included

Website

http://www.cogentbio.com

Employees

205

Key Details

Price

$4.64(+2.88%)

Market cap

$528.26M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.94(0.00% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.64
COGT price is $4.64

30-Day Relative Volume

0.71
COGT 30-day relative volume is 0.71

Price Performance

Price Most recent change

+2.88%
COGT price was up +2.88% on Apr 25, 2025

Price YTD change

-40.51%
COGT price is down -40.51% since January 1st

Price 1-year change

-22.8%
COGT price is down -22.8% year-on-year

Price 3-year change

-34.56%
COGT price is down -34.56% over the past 3 years

Price Range

Price All-time high

$70.64
COGT price is currently -93.43% below its historical high of $70.64

Price 3-year low

$3.67
COGT price is currently +26.43% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$528.26M
COGT market capitalization is $528.26 million

Market cap 3-year change

+62.61%
COGT market capitalization is up +62.61% over the past 3 years

Market cap All-time high

$1.39B
COGT market capitalization is currently -61.95% below its historical high of $1.39 billion

Market cap sector rank

68.77%
COGT market capitalization is higher than 68.77% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+19.07%
COGT shares outstanding is up +19.07% year-on-year

Shares Outstanding 3-Year Change

+148.48%
COGT shares outstanding is up +148.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.43
COGT beta is 1.43

200-day SMA

$8.82
COGT price is currently -47.37% below its 200-day simple moving average

50-day SMA

$6.33
COGT price is currently -26.65% below its 50-day simple moving average

RSI

40.19
COGT 14-day relative strength index is 40.19

Volume

0.71
COGT 30-day relative volume is 0.71

ATR

$0.39
COGT average true range is $0.39

10-day Historical Volatility

89.41%
COGT 10-day historical volatility is 89.41%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
COGT annual revenue value is unknown

Revenue Analysts estimate

-
COGT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
COGT annual revenue 1-year change is unknown

Revenue Sector rank

-
COGT annual revenue is unknown

EPS

EPS

-$1.94
COGT annual earnings per share is -$1.94

EPS Analysts estimate

-$2.18
COGT annual earnings per share is currently -11.02% lower than the consensus analysts' forecast

EPS 1-year change

0%
COGT {parameterFullLabel} has remained unchanged year-on-year

EPS Sector rank

39.07%
COGT annual earnings per share is higher than 39.07% of companies in Healthcare sector

Profit

Gross profit

-
COGT annual gross profit value is unknown

Gross margin

-
COGT annual gross profit margin value is unknown

Operating profit

-$275.94M
COGT annual operating income is -$275.94 million

Operating margin

-
COGT annual operating profit margin value is unknown

Net income

-$255.86M
COGT annual net profit is -$255.86 million

Net margin

-
COGT annual net profit margin value is unknown

Expenses

Total expenses

$275.94M
COGT annual total expenses is $275.94 million

Operating expenses

$275.94M
COGT annual total operating expenses is $275.94 million

Cost of goods sold

-
COGT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$43.28M
COGT annual SGA is $43.28 million

Depreciation and amortization

$4.35M
COGT annual depreciation & amortization is $4.35 million

Interest expense

-
COGT annual interest expense value is unknown

Income tax

-
COGT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$275.94M
COGT annual earnings before interest & taxes is -$275.94 million

EBITDA

-$271.59M
COGT annual EBITDA is -$271.59 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$327.90M
COGT annual total assets is $327.90 million

Non current assets

$31.43M
COGT annual long term assets is $31.43 million

Current assets

$296.47M
COGT annual total current assets is $296.47 million

Cash and cash equivalents

$98.17M
COGT annual cash & cash equivalents is $98.17 million

Accounts receivable

-
COGT annual accounts receivable value is unknown

Inventory

-
COGT annual inventory value is unknown

Liabilities

Total liabilities

$71.61M
COGT annual total liabilities is $71.61 million

Long term liabilities

$15.90M
COGT annual total long term liabilities is $15.90 million

Current liabilities

$55.71M
COGT annual total current liabilities is $55.71 million

Accounts payable

$12.01M
COGT annual accounts payable is $12.01 million

Debt

Total debt

$17.47M
COGT annual total debt is $17.47 million

Total debt 1-year change

-7.35%
COGT annual total debt is down -7.35% year-on-year

Long term debt

$15.90M
COGT annual long term debt is $15.90 million

Short term debt

$1.56M
COGT annual short term debt is $1.56 million

Equity & Capital

Shareholders equity

$256.29M
COGT annual stockholders equity is $256.29 million

Book value

$145.69M
COGT annual book value is $145.69 million

Retained earnings

-$859.48M
COGT annual retained earnings is -$859.48 million

Working capital

$240.76M
COGT annual working capital is $240.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$207.79M
COGT annual cash flow from operations is -$207.79 million

Cash from operations 1-year change

-35.26%
COGT annual cash flow from operations is down -35.26% year-on-year

Cash from investing

$38.28M
COGT annual cash flow from investing activities is $38.28 million

Cash from investing 1-year change

+139.13%
COGT annual cash flow from investing activities is up +139.13% year-on-year

Cash from financing

$214.45M
COGT annual cash flow from financing activities is $214.45 million

Cash from financing 1-year change

+31.13%
COGT annual cash flow from financing activities is up +31.13% year-on-year

CAPEX

CAPEX

-
COGT annual capital expenditures value is unknown

CAPEX 1-year change

-
COGT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$208.36M
COGT annual free cash flow is -$208.36 million

Free cash flow 1-year change

-33.21%
COGT annual free cash flow is down -33.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
COGT annual gross profit margin value is unknown

Operating margin

-
COGT annual operating profit margin value is unknown

Net margin

-
COGT annual net profit margin value is unknown

ROA & ROE

ROA

-78.03%
COGT annual return on assets is -78.03%

ROE

-99.83%
COGT annual return on equity is -99.83%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
COGT price to earnings ratio value is unknown

PE ratio Sector rank

-
COGT price to earnings ratio is unknown

PB Ratio

PB ratio

3.63
COGT price to book ratio is 3.63

PB ratio Sector rank

76%
COGT price to book ratio is higher than 76% of companies in Healthcare sector

PS Ratio

PS ratio

-
COGT price to sales ratio value is unknown

PS ratio Sector rank

-
COGT price to sales ratio is unknown

Enterprise value

Enterprise value

$447.57M
COGT enterprise value is $447.57 million

Enterprise value Sector rank

66.97%
COGT enterprise value is higher than 66.97% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.65
COGT EV/EBITDA is -1.65

EV/EBITDA Sector rank

37.64%
COGT EV/EBITDA is higher than 37.64% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.32
COGT annual current ratio is 5.32

Quick ratio

-
COGT annual quick ratio value is unknown

Leverage

Debt to equity

0.07
COGT annual debt to equity ratio is 0.07

Interest coverage ratio

-
COGT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
COGT piotroski f-score value is unknown

Altman Z-Score

-
COGT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 7, 25 Scotiabank
Sector Outperform
Feb 27, 25 Baird
Neutral
Feb 26, 25 Needham
Hold
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 11, 24 Needham
Hold
Dec 11, 24 HC Wainwright & Co.
Buy
Dec 10, 24 Needham
Buy
Dec 9, 24 Needham
Buy
Nov 14, 24 JP Morgan
Overweight
Nov 13, 24 Needham
Buy

Institutional Ownership

Similar stocks

MGTX logo
MeiraGTx Holdings (MGTX)
STOK logo
Stoke Therapeutics (STOK)
TALK logo
Talkspace (TALK)
OPT logo
Opthea Limited (OPT)
TYRA logo
Tyra Biosciences (TYRA)
Fortrea Holdings (FTRE)
PRTA logo
Prothena (PRTA)
KIDS logo
OrthoPediatrics (KIDS)
Sionna Therapeutics (SION)
  • What is the ticker symbol for Cogent Biosciences?
  • Does Cogent Biosciences pay dividends?
  • What sector is Cogent Biosciences in?
  • What industry is Cogent Biosciences in?
  • What country is Cogent Biosciences based in?
  • When did Cogent Biosciences go public?
  • Is Cogent Biosciences in the S&P 500?
  • Is Cogent Biosciences in the NASDAQ 100?
  • Is Cogent Biosciences in the Dow Jones?
  • When was Cogent Biosciences's last earnings report?
  • When does Cogent Biosciences report earnings?
  • Should I buy Cogent Biosciences stock now?

What is the ticker symbol for Cogent Biosciences?

The ticker symbol for Cogent Biosciences is NASDAQ:COGT

Does Cogent Biosciences pay dividends?

No, Cogent Biosciences does not pay dividends

What sector is Cogent Biosciences in?

Cogent Biosciences is in the Healthcare sector

What industry is Cogent Biosciences in?

Cogent Biosciences is in the Biotechnology industry

What country is Cogent Biosciences based in?

Cogent Biosciences is headquartered in United States

When did Cogent Biosciences go public?

Cogent Biosciences's initial public offering (IPO) was on March 29, 2018

Is Cogent Biosciences in the S&P 500?

No, Cogent Biosciences is not included in the S&P 500 index

Is Cogent Biosciences in the NASDAQ 100?

No, Cogent Biosciences is not included in the NASDAQ 100 index

Is Cogent Biosciences in the Dow Jones?

No, Cogent Biosciences is not included in the Dow Jones index

When was Cogent Biosciences's last earnings report?

Cogent Biosciences's most recent earnings report was on Feb 25, 2025

When does Cogent Biosciences report earnings?

The next expected earnings date for Cogent Biosciences is May 7, 2025

Should I buy Cogent Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page